Clinical Trial Update: Mass Balance Recovery and Metabolite Identification of Carbon-14 BIA 28-6156 [Phase 1]

View source ↗

Summary

Phase 1 study reporting mass balance recovery and metabolite identification for the carbon-14 labeled compound BIA 28-6156 in participants with Parkinson diseas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• BIA 28-6156

Snippet

Sponsor: Bial R&D Investments, S.A. | Conditions: Parkinson Disease | Phase 1 | Status: COMPLETED